{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-229184","form_type":"8-K","ticker":"PBYI","cik":"0001401667","company_name":"PUMA BIOTECHNOLOGY, INC.","filed_at":"2021-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.953658+00:00","generated_at":"2026-06-30T00:54:48.107445+00:00","sec_items":["1.01","2.03"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Puma Biotechnology enters $100M note purchase agreement to refinance prior credit facility","bullets":["Issued $100M notes to Athyrium; $25M additional available; used proceeds plus ~$9.2M to repay prior $100M facility.","Notes bear 8.0% + 3-month LIBOR; quarterly interest; principal amortization starts June 2024, maturity July 2026.","Covenants require minimum cash and minimum NERLYNX-based revenue; secured by substantially all assets including IP.","Prepayment fees: make-whole within 2 years, 2% thereafter to year 3; exit fee 2% on any prepayment.","Restrictions on additional debt, dividends, mergers, asset sales, and change of control."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-229184","json":"https://secwatch.observer/filing/0001193125-21-229184.json","markdown":"https://secwatch.observer/filing/0001193125-21-229184.md","text":"https://secwatch.observer/filing/0001193125-21-229184.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401667/000119312521229184/0001193125-21-229184-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401667/000119312521229184/d155853d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T00:54:48.107445+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}